START MidWest — Grand Rapids, Michigan

START MidWest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

START MidWest has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumors, Pancreatic Cancer, Non Small Cell Lung Cancer.

Sponsors: AstraZeneca, Asana BioSciences, Klus Pharma Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START MidWest?

START MidWest has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START MidWest conducted?

START MidWest has 5 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors, Pancreatic Cancer, Non Small Cell Lung Cancer.

Is START MidWest accredited by Crixeo Health?

Yes — START MidWest holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about START MidWest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.